SCOPUS 정보 검색 플랫폼

Volumn 190, Issue 2, 2009, Pages 100-

(4) Chow, Elizabeth C Y a Teo, Marcus a Ring, John A a Chen, John W a

Author keywords

[No Author keywords available]

Indexed keywords

CIMICIFUGA RACEMOSA EXTRACT;

ARTHRALGIA; AUSTRALIA; CIMICIFUGA RACEMOSA; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; DRUG LABELING; DRUG SAFETY; DRUG WITHDRAWAL; EVIDENCE BASED MEDICINE; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; LETHARGY; LETTER; LIVER BIOPSY; LIVER FAILURE; MEDICAL RESEARCH; MENOPAUSAL SYNDROME; NAUSEA; PROVOCATION TEST; RESEARCH ETHICS; UNITED KINGDOM;

EID: 59349088020 PISSN: 0025729X EISSN: None Source Type: Journal
DOI: None Document Type: Letter

Times cited : (3)

References (7)

1
- 46249096117
- Liver failure associated with the use of black cohosh for menopausal symptoms
- Chow ECY, Teo M, Ring JA, Chen JW. Liver failure associated with the use of black cohosh for menopausal symptoms. Med J Aust 2008; 188: 420-422.
- (2008) Med J Aust , vol.188 , pp. 420-422
- Chow, E.C.Y.¹ Teo, M.² Ring, J.A.³ Chen, J.W.⁴

2
- 38349051228
- Black cohosh: A cause of abnormal postmenopausal liver function tests
- Joy D, Joy J, Duane P. Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric 2008; 11: 84-88.
- (2008) Climacteric , vol.11 , pp. 84-88
- Joy, D.¹ Joy, J.² Duane, P.³

3
- 59349104342
- Committee on Herbal Medicinal Products (HMPC)
- London: EMEA, accessed Oct 2008
- European Medicines Agency, Committee on Herbal Medicinal Products (HMPC). Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root). London: EMEA, 2007. http://www.emea.europa.eu/pdfs/human/hmpc/ 26925806en.pdf (accessed Oct 2008).
- (2007) Assessment of case reports connected to herbal medicinal products containing Cimicifugae racemosae rhizoma (black cohosh, root)

4
- 38549157627
- Hepatic effects of Cimifuga racemosa extract in vivo and in vitro
- Lüde S, Török M, Dieterle S, et al. Hepatic effects of Cimifuga racemosa extract in vivo and in vitro. Cell Mol Life Sci 2007; 64: 2848-2857.
- (2007) Cell Mol Life Sci , vol.64 , pp. 2848-2857
- Lüde, S.¹ Török, M.² Dieterle, S.³

5
- 59349113498
- Australian Government Department of Health and Ageing Therapuetic Goods Administration, Canberra:, accessed Oct 2008
- Australian Government Department of Health and Ageing Therapuetic Goods Administration. Required advisory statements for medicine labels. Proposed update 3.1, consultation document. Canberra: Australian Government, 2007. http://www.tga.gov.au/meds/drrasmlupd3-1.pdf (accessed Oct 2008).
- (2007) Required advisory statements for medicine labels. Proposed update 3.1, consultation document

6
- 59349099606
- UK Public Assessment Report, 31 Jul, accessed Oct 2008
- Medicines and Healthcare Products Regulatory Agency. Black cohosh. UK Public Assessment Report, 31 Jul 2006. http://www.mhra.gov.uk/home/ groups/es-herbal/documents/websiteresources/con2024279.pdf (accessed Oct 2008).
- (2006) Black cohosh

7
- 59349115329
- Canada is advising consumers about a possible link between black cohosh and liver damage [advisory, Ottawa: Health Canada, 2006, accessed Sep 2006
- Health Canada. Health Canada is advising consumers about a possible link between black cohosh and liver damage [advisory]. Ottawa: Health Canada, 2006. http://www.hc-sc.gc.ca/ahc-asc/media/advisories-avis/2006/ 2006_72_e.html (accessed Sep 2006).
- Health Canada. Health

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.